Immediate Impact
4 from Science/Nature 75 standout
Citing Papers
Pancreatic cancer
2025 Standout
Pancreatic cancer: Advances and challenges
2023 Standout
Works of Shaul Kadosh being referenced
A Multi-Center Phase IIA Trial to Assess the Safety and Efficacy of BL-8040 (a CXCR4 Inhibitor) in Combination with Pembrolizumab and Chemotherapy in Patients with Metastatic Pancreatic Adenocarcinoma (PDAC)
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Shaul Kadosh | 322 | 24 | 184 | 109 | 10 | 414 | |
| George Katsamakis | 215 | 27 | 137 | 50 | 7 | 456 | |
| J Furby | 325 | 6 | 119 | 105 | 8 | 392 | |
| S. L. Braheny | 300 | 19 | 148 | 88 | 9 | 430 | |
| Lynn Stazzone | 415 | 24 | 151 | 72 | 10 | 510 | |
| Amer Awad | 278 | 22 | 125 | 79 | 14 | 419 | |
| Nuhad Abou Zeid | 365 | 23 | 172 | 103 | 7 | 439 | |
| Stella Huang | 277 | 18 | 74 | 79 | 8 | 394 | |
| R. A. Koopmans | 375 | 20 | 137 | 112 | 12 | 442 | |
| D. Farina | 319 | 17 | 96 | 85 | 14 | 424 | |
| G. S. M. Ramsaransing | 359 | 14 | 137 | 129 | 13 | 485 |
All Works
Loading papers...